Skip to main content
NIH funding notice PAR-23-200

NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

Closed on January 6, 2025.

Posted
June 27, 2023
Close date
January 6, 2025
Activity codes
R61, R33
Institutes taking part
NEI

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page names no earlier notice: it is new, or it does not say.

Replaced by PAR-28-072.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $774,169 in first-year total cost, median $774,169.

Most frequent study sections

  1. Special Emphasis Panel[ZEY1 VSN (06)]1

Most frequent institutions

  1. COLUMBIA UNIVERSITY HEALTH SCIENCES1
Competing awards under PAR-23-200 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Advancing the small molecule drug candidate with dual specificity as a therapy for dry AMD1R61EY036287-01CIOFFI, CHRISTOPHER L.PETRUKHIN, KONSTANTINCOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$774,169ZEY1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.